Growth Metrics

Immucell (ICCC) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to $2.6 million.

  • Immucell's Receivables - Net rose 1069.59% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 1069.59%. This contributed to the annual value of $3.8 million for FY2024, which is 7256.17% up from last year.
  • Latest data reveals that Immucell reported Receivables - Net of $2.6 million as of Q3 2025, which was up 1069.59% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, Immucell's Receivables - Net ranged from a high of $3.8 million in Q4 2024 and a low of $1.4 million during Q2 2022
  • Over the past 5 years, Immucell's median Receivables - Net value was $2.3 million (recorded in 2024), while the average stood at $2.3 million.
  • Per our database at Business Quant, Immucell's Receivables - Net skyrocketed by 10857.22% in 2021 and then plummeted by 3472.72% in 2022.
  • Quarter analysis of 5 years shows Immucell's Receivables - Net stood at $2.7 million in 2021, then tumbled by 34.73% to $1.8 million in 2022, then increased by 24.27% to $2.2 million in 2023, then surged by 72.56% to $3.8 million in 2024, then tumbled by 32.25% to $2.6 million in 2025.
  • Its Receivables - Net stands at $2.6 million for Q3 2025, versus $2.4 million for Q2 2025 and $3.3 million for Q1 2025.